Oral choline supplementation in children with intestinal failure

J Pediatr Gastroenterol Nutr. 2011 Jul;53(1):115-9. doi: 10.1097/MPG.0b013e31821404d4.

Abstract

Choline deficiency leads to steatohepatitis, elevated transaminases, susceptibility to septic shock, and an increased risk of central catheter thrombosis. Children with intestinal failure (IF) are at risk for choline deficiency. In an unblinded, open-label study, we studied 7 children with IF on parenteral nutrition, measured their plasma free choline level, and, if low, supplemented enterally with adequate intake (AI) doses of choline. Four to 6 weeks later we remeasured their plasma free choline. Unlike adults, infants did not respond to oral choline supplementation at AI doses. Additionally, we have calculated plasma free choline percentiles versus age for normal children.

Publication types

  • Clinical Trial

MeSH terms

  • Administration, Oral
  • Adolescent
  • Age Factors
  • Child
  • Choline / blood
  • Choline / therapeutic use*
  • Choline Deficiency / etiology
  • Choline Deficiency / prevention & control
  • Dietary Supplements*
  • Female
  • Humans
  • Infant
  • Intestinal Diseases / blood
  • Intestinal Diseases / diet therapy*
  • Intestinal Diseases / physiopathology
  • Intestines / physiopathology*
  • Male
  • Parenteral Nutrition
  • Pilot Projects
  • Short Bowel Syndrome / blood
  • Short Bowel Syndrome / diet therapy
  • Short Bowel Syndrome / physiopathology

Substances

  • Choline